Sino Biological,Inc. (SHE:301047)
China flag China · Delayed Price · Currency is CNY
91.92
-7.28 (-7.34%)
Nov 16, 2026, 4:00 PM EST

Sino Biological,Inc. Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
763.73671.3587.29630.95574.6965.27
Other Revenue
28.2728.2726.3815.44--
791.99699.56613.67646.39574.6965.27
Revenue Growth
19.97%14.00%-5.06%12.49%-40.47%-39.53%
Cost of Revenue
210.64190.48170.98125.8595.0168.98
Gross Profit
581.35509.09442.69520.54479.59896.29
Selling, General & Admin
336.64310.79305.19280.26207.29141.48
Research & Development
83.2686.2291.2187.4560.1540.13
Other Operating Expenses
17.8914.988.746.038.3613.45
Operating Expenses
449.43418.88413.4384.78276.06199.74
Operating Income
131.9290.2129.29135.76203.53696.56
Interest Expense
-2.38-3.09-3.98-3.73-2.77-2.01
Interest & Investment Income
53.667.47103.6136.28129.4954.58
Currency Exchange Gain (Loss)
-3.44-3.44-1.61.8412.05-8.07
Other Non Operating Income (Expenses)
-13.05-0.32-0.62-0.45-0.4-0.63
EBT Excluding Unusual Items
166.65150.84126.7269.71341.9740.43
Gain (Loss) on Sale of Investments
40.0224.634.8810.98-14.3834.14
Gain (Loss) on Sale of Assets
0.390.54-0.350.050.21-0.01
Asset Writedown
-1.09-----
Other Unusual Items
9.013.5410.17.2114.7870.89
Pretax Income
214.98179.54141.33287.95342.51845.45
Income Tax Expense
35.9131.819.4127.8239.55125.44
Net Income
179.07147.74121.93260.13302.96720.01
Net Income to Common
179.07147.74121.93260.13302.96720.01
Net Income Growth
34.85%21.17%-53.13%-14.14%-57.92%-36.15%
Shares Outstanding (Basic)
122122128129114108
Shares Outstanding (Diluted)
122122128129114108
Shares Change
-1.52%-4.93%-0.97%13.44%5.79%11.11%
EPS (Basic)
1.471.210.952.012.666.69
EPS (Diluted)
1.471.210.952.012.666.69
EPS Growth
36.94%27.45%-52.67%-24.30%-60.22%-42.53%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
54.8945.1443.78-720.893.34594.72
Free Cash Flow Per Share
0.450.370.34-5.580.825.52
Dividend Per Share
2.2005.2001.0002.0002.0005.263
Dividend Growth
-56.00%420.00%-50.00%0%-62.00%-
Gross Margin
73.40%72.77%72.14%80.53%83.47%92.85%
Operating Margin
16.66%12.90%4.77%21.00%35.42%72.16%
Profit Margin
22.61%21.12%19.87%40.24%52.73%74.59%
Free Cash Flow Margin
6.93%6.45%7.13%-111.51%16.24%61.61%
EBITDA
196.82155.3494.72182.03221.27708.9
EBITDA Margin
24.85%22.20%15.44%28.16%38.51%73.44%
D&A For EBITDA
64.965.1365.4346.2617.7412.35
EBIT
131.9290.2129.29135.76203.53696.56
EBIT Margin
16.66%12.90%4.77%21.00%35.42%72.16%
Effective Tax Rate
16.71%17.71%13.73%9.66%11.55%14.84%
Revenue as Reported
791.99699.56613.67646.39574.6965.27
Advertising Expenses
-23.5328.1834.4336.9525.14